Notice Number: NOT-FD-18-010
Release Date: April 24, 2018
U.S. Food and Drug Administration (FDA)
FDA's RFA-FD-18-019 - Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems (U01)has made updates to its sections on page 2 & 3 titled " Application Due Date(s) and Expiration Date ". See revised sections below:
Application Due Date(s)
May 29, 2018, by 11:59 PM Eastern Time.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
May 30, 2018
Please direct all inquiries to:
Eleftheria Tsakalozou, PhD